Log In
BCIQ
Print this Print this
 

taladegib (LY2940680)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSmall molecule antagonist of smoothened (SMO) and inhibitor of sonic hedgehog homolog (SHH)
Molecular Target Smoothened (SMO) ; Sonic hedgehog homolog (SHH)
Mechanism of ActionSmoothened antagonist; Sonic hedgehog homolog (SHH) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$53.0M

$2.0M

$38.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/08/2015

$53.0M

$2.0M

$38.0M

Get a free BioCentury trial today